Another Reason to Believe Pfizer Could Have a Coronavirus Vaccine Ready in October

"We will go for regulatory approvals in October."

Those were the words of Pfizer (NYSE:PFE) CEO Albert Bourla in a Washington Post live interview earlier this month. He was referring to the prospect that the company, along with its partner BioNTech (NASDAQ:BNTX), could seek approval for COVID-19 vaccine candidate BNT162b2 in the near future.